Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Healthy Individuals
NCT07804537 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2026-09-04
Summary
To study the effect of a re-ascent to high altitude (Quito Ecuador: 2850m) after a one-week stay at sea level (after prior descent from 2850m) on lung function and pulmonary resistance/reactance in healthy individuals, who live permanently \> 2600m.
Conditions
- Healthy
- Healthy Adult
- High Altitude Effects
- High Altitude
- Lung Function Tests
- Lung Function Changes
Interventions
- BEHAVIORAL
-
Re-ascent from sea level to 2850m
Descent from 2850m to sea level with a stay for 7 days and re-ascent/return back to their usual living altitude at 2850m
Sponsors & Collaborators
-
Silvia Ulrich Somaini
lead OTHER
Principal Investigators
-
Silvia Ulrich · University Hospital Zurich, Departement of Pulmonology
-
Rodrigo Hoyos · Hospital Carlos Andrade Marin of Quito, Ecuador
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-09-25
- Primary Completion
- 2026-10-04
- Completion
- 2026-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Healthy Individuals H
NCT07804485 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Healthy Individuals H
NCT07801950 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Six-minute Walking Distance Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH
NCT07797166 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sleep-Assessment in Patients Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH
NCT07801963 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Patients With Pulmonary Arterial Hypertension PAH
NCT07804693 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Total Pulmonary Resistance sPAP/CO Between High Altitude HA vs. Sea Level LA in Patients With Pulmonary Arterial Hypertension PAH
NCT07804524 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Healthy Individuals H
NCT07801846 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Patients With Pulmonary Arterial Hypertension PAH
NCT07801859 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hypoxia-altitude Testing to Predict Altitude Related Adverse Health Effects in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT04915378 ·Status: COMPLETED
-
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
NCT06072417 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Acute Exposure of High Altitude on Cognitive Function
NCT03637192 ·Status: COMPLETED ·Phase: NA
-
Acute Exposure to High Altitude on Heart Rate and Ventilation During Exercise
NCT03593096 ·Status: COMPLETED ·Phase: NA
-
Exercise Performance on Ambient Air vs. Low-Flow Liquid Oxygen Therapy in Chronic Lung Diseases
NCT07777367 ·Status: RECRUITING ·Phase: NA
-
High Altitude (HA) Residents With Pulmonary Vascular Diseseases (PVD), Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) vs Sea Level (LA)
NCT06092424 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Acute Exposure of Simulated Hypoxia on Heart Rate and Ventilation During Exercise
NCT03592979 ·Status: COMPLETED ·Phase: NA
-
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)
NCT05996302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance
NCT02143687 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of High Altitude Exposure, Acclimatization and Re-exposure on Nocturnal Breathing Pattern in Lowlanders
NCT02730143 ·Status: COMPLETED ·Phase: NA
-
Effect of High Altitude Exposure, Acclimatization and Re-exposure on Lung Water Content by Ultrasound
NCT02760186 ·Status: COMPLETED ·Phase: NA
-
Acute Exposure to High Altitude on Pulmonary Artery Pressure and Right Heart Function (Echo) Under Exercise
NCT03637179 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects of Iron Levels on the Lungs at High Altitude
NCT00952302 ·Status: COMPLETED ·Phase: NA
-
Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep
NCT02150616 ·Status: UNKNOWN ·Phase: PHASE4
-
Acute Exposure to Simulated Hypoxia on Exercise Capacity
NCT03592927 ·Status: COMPLETED ·Phase: NA
-
Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m
NCT05112172 ·Status: COMPLETED ·Phase: NA
-
Exercise Endurance Time on the 2nd Day at 2500 m High Altitude
NCT05131737 ·Status: COMPLETED ·Phase: NA